Study to Evaluate the Efficacy and Safety of Satralizumab in FSHD1

Clinical trial NCT06222827 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT06222827

Sponsor

Centre Hospitalier Universitaire de Nice

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2024-01-24

Primary completion

2027-03-01

Enrollment

46

View on ClinicalTrials.gov